UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000011690
Receipt number R000013668
Scientific Title Efficacy of endoscopic submucosal dissection for gastrointestinal subepithelial tumors within the submucosa: multicenter study
Date of disclosure of the study information 2013/11/01
Last modified on 2020/03/16 17:26:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of endoscopic submucosal dissection for gastrointestinal subepithelial tumors within the submucosa: multicenter study

Acronym

Endoscopic submucosal dissection for gastrointestinal subepithelial tumor within the submucosa

Scientific Title

Efficacy of endoscopic submucosal dissection for gastrointestinal subepithelial tumors within the submucosa: multicenter study

Scientific Title:Acronym

Endoscopic submucosal dissection for gastrointestinal subepithelial tumor within the submucosa

Region

Japan


Condition

Condition

gastrointestinal subepithelial tumors within submucosa

Classification by specialty

Gastroenterology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We invetigate the efficacy, safety, and long term result of endoscopic submucosal dissection for gastrointestinal subepithelial tumors within submucosa

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

en bloc rection rate

Key secondary outcomes

complications, procedure time, emergency,emergency surgery migration rate, additional surgery rate, recurrence rate, survival observation period


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

endoscopic submucosal dissection:ESD

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.lesion contained within the SM layer
2.all patients whom informed consents were obtained
3. symptomatic SET strongly suspected to be a benign tumor on conventional endoscopic imaging, EUS and computed tomography
4.Tumor with the increasing tendency of tumor size greater than 1.5 times the rate before
5. confirmed histological diagnosis of carcinoid tumor; carcinoid tumor 10 mm; no lymph node or distant metastasis found
6. Granular cell tumor confirmed by preoperative tissue diagnosis
7. Indefinite SMT which is suspected malignancy in the image preoperatively

Key exclusion criteria

1.We exclude cysts, lipoma and vascular lesions with typical features in the image and asymptomatic symptoms
2.Lesions postoperative stenosis is expected, beyond the half cercumferential lumen
3.Lesions that can not check the remaining submucosa of the third layer by EUS
4.patients who do not meeting the following conditions: physical status I
to II and normal complete blood cell counts and prothrombin times are excluded

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Hideki
Middle name
Last name Kobara

Organization

Faculty of Medicine, Kagawa University

Division name

Gastroenterology and Neurology

Zip code

761-0793

Address

Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan

TEL

087-891-2156

Email

kobara@med.kagawa-u.ac.jp


Public contact

Name of contact person

1st name Hideki
Middle name
Last name Kobara

Organization

Kagawa University Hospital

Division name

Gastroenterology and Neurology

Zip code

761-0793

Address

Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan

TEL

087-898-5111

Homepage URL


Email

kobara@med.kagawa-u.ac.jp


Sponsor or person

Institute

Kagawa University Hospital

Institute

Department

Personal name



Funding Source

Organization

Kagawa University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Ehime University Hospital, Kagawa Saiseikai hospital, Kochi Medical Center, Kochi Red Cross Hospital, Shimane Prefectural Central Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Faculty of Medicine, Kagawa University

Address

1750-1 Ikenobe, Miki, Kita

Tel

0878985111

Email

chosa@med.kagawa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 11 Month 01 Day


Related information

URL releasing protocol

N/A

Publication of results

Unpublished


Result

URL related to results and publications

Possible

Number of participants that the trial has enrolled

57

Results

The rates of en bloc resection, curative resection, complications were 98.2%, 66.7%, 7.7% for overall (n=57), 100%, 61.9%, 2.4% for NET (n=42), and 93.3%, 80%, 20% for indeterminate SELs (n=15), respectively. The rates of curative resection were poor with 20% in stomach (n=5), 33% in duodenum (n=3), compared with 71% in rectum (n=24). Including conservative approach for 11 of 16 NETs who resulted in non-curative resection, no tumor recurrences occurred in all cases during follow-up period.

Results date posted

2019 Year 09 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

57 consecutive patients (35 males, 22 females, median age: 63 years, range: 32-86 years) with GI SELs were analyzed, and were divided into definite NET (n=42) and indeterminate SELs (n=15) including one symptomatic SEL.

Participant flow

All patients were evaluated by routine endosonography (EUS: high-frequency miniprobe, 20 MHz, UM-3R; Olympus, Tokyo, Japan) and enhanced CT. All data were extracted and compiled into a central database at Kagawa University.

Adverse events

Complications included the incidence of any bleeding requiring an endoscopic hemostatic procedure. Perforation was defined as GI wall penetration observed during or after the procedure. Severe complication was defined as the requirement of immediate surgery repair.

Outcome measures

The overall rates of en bloc resection, curative resection, complications, and procedure time of all 57 cases were evaluated.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 08 Month 29 Day

Date of IRB

2013 Year 08 Month 29 Day

Anticipated trial start date

2013 Year 09 Month 15 Day

Last follow-up date

2018 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2020 Year 03 Month 13 Day


Other

Other related information



Management information

Registered date

2013 Year 09 Month 09 Day

Last modified on

2020 Year 03 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013668


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name